Evaluation of the Influence of <i>CYP2C9* 2, CYP2C9*3</i> Gene Polymorphisms on the Efficacy and Safety of Postoperative Analgesia with Ketoprofen in Patients after Cardiac Surgery
Aim. The aim of the study was to evaluate the efficacy and safety of ketoprofen as an analgesic therapy in patients with CYP2C9*2 (430C>T) rs179985 and CYP2C9*3 (1075A>C) rs1057910 gene polymorphisms after cardiac surgery.Material and methods. The study included 90 patients. Postoperat...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2021-09-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/2539 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849227574716137472 |
|---|---|
| author | T. E. Morozova D. A. Shatsky N. V. Shikh E. V. Shikh T. B. Andrushchyshina M. V. Lukina A. A. Kachanova Zh. A. Sozaeva G. N. Shuev N. P. Denisenko E. A. Grishina D. A. Sychev |
| author_facet | T. E. Morozova D. A. Shatsky N. V. Shikh E. V. Shikh T. B. Andrushchyshina M. V. Lukina A. A. Kachanova Zh. A. Sozaeva G. N. Shuev N. P. Denisenko E. A. Grishina D. A. Sychev |
| author_sort | T. E. Morozova |
| collection | DOAJ |
| description | Aim. The aim of the study was to evaluate the efficacy and safety of ketoprofen as an analgesic therapy in patients with CYP2C9*2 (430C>T) rs179985 and CYP2C9*3 (1075A>C) rs1057910 gene polymorphisms after cardiac surgery.Material and methods. The study included 90 patients. Postoperative analgesia was perfomed by ketoprofen 100 mg intramuscularly twice daily. The evaluation of pain was determined daily by Numeric Rating Scale for 5 days after cardiac surgery. The safety of ketoprofen was determined by assessing the severity of gastroenterological symptoms using the Gastrointestinal Symptom Rating Scale questionnaire and determining the frequency of episodes of acute kidney injury. The material for DNA was venous blood. To determine the single nucleotide genetic polymorphisms CYP2C9*2 (430C>T) rs179985 and CYP2C9*3 (1075A>C) rs1057910, the real-time polymerase chain reaction was used.Results. In patients with the AA genotype of CYP2C9*3 polymorphism, the intensity of pain on the numeric rating scale scale (points) was significantly higher than in patients with the AC genotype: 7 [6; 8] vs 6 [5; 6] (р=0,003), 7 [6; 8] vs 6 [5; 6] (р=0,04), 6 [5; 7] vs 5 [4; 5] (р=0,04), 5 [3; 6] vs 3 [3; 4] points (р=0,02) on days 1, 2, 3 and 5 of the postoperative period, respectively. The severity of gastroenterological symptoms was higher in patients with a heterozygous CT genotype for the allelic variant CYP2C9*2 than in patients with a wild CС genotype and amounted to 19 [19; 22] vs 18 [16; 20] points, respectively, (p=0,04). The distribution of genotypes for CYP2C9*2 polymorphisms and CYP2C9*3 polymorphisms between the groups of acute renal injury did not differ significantly.Conclusion. Associations of polymorphisms CYP2C9*3 with a lower intensity of pain syndrome and CYP2C9*2 with a greater severity of gastroenterological symptoms were revealed. |
| format | Article |
| id | doaj-art-544a1dde8efd4fd1af17a485b0e980f3 |
| institution | Kabale University |
| issn | 1819-6446 2225-3653 |
| language | English |
| publishDate | 2021-09-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj-art-544a1dde8efd4fd1af17a485b0e980f32025-08-23T10:00:34ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532021-09-0117457057510.20996/1819-6446-2021-08-121931Evaluation of the Influence of <i>CYP2C9* 2, CYP2C9*3</i> Gene Polymorphisms on the Efficacy and Safety of Postoperative Analgesia with Ketoprofen in Patients after Cardiac SurgeryT. E. Morozova0D. A. Shatsky1N. V. Shikh2E. V. Shikh3T. B. Andrushchyshina4M. V. Lukina5A. A. Kachanova6Zh. A. Sozaeva7G. N. Shuev8N. P. Denisenko9E. A. Grishina10D. A. Sychev11I.M. Sechenov First Moscow State Medical UniversityI.M. Sechenov First Moscow State Medical UniversityI.M. Sechenov First Moscow State Medical UniversityI.M. Sechenov First Moscow State Medical UniversityI.M. Sechenov First Moscow State Medical UniversityI.M. Sechenov First Moscow State Medical UniversityRussian Medical Academy of Continuing Professional EducationRussian Medical Academy of Continuing Professional EducationRussian Medical Academy of Continuing Professional EducationRussian Medical Academy of Continuing Professional EducationRussian Medical Academy of Continuing Professional EducationRussian Medical Academy of Continuing Professional EducationAim. The aim of the study was to evaluate the efficacy and safety of ketoprofen as an analgesic therapy in patients with CYP2C9*2 (430C>T) rs179985 and CYP2C9*3 (1075A>C) rs1057910 gene polymorphisms after cardiac surgery.Material and methods. The study included 90 patients. Postoperative analgesia was perfomed by ketoprofen 100 mg intramuscularly twice daily. The evaluation of pain was determined daily by Numeric Rating Scale for 5 days after cardiac surgery. The safety of ketoprofen was determined by assessing the severity of gastroenterological symptoms using the Gastrointestinal Symptom Rating Scale questionnaire and determining the frequency of episodes of acute kidney injury. The material for DNA was venous blood. To determine the single nucleotide genetic polymorphisms CYP2C9*2 (430C>T) rs179985 and CYP2C9*3 (1075A>C) rs1057910, the real-time polymerase chain reaction was used.Results. In patients with the AA genotype of CYP2C9*3 polymorphism, the intensity of pain on the numeric rating scale scale (points) was significantly higher than in patients with the AC genotype: 7 [6; 8] vs 6 [5; 6] (р=0,003), 7 [6; 8] vs 6 [5; 6] (р=0,04), 6 [5; 7] vs 5 [4; 5] (р=0,04), 5 [3; 6] vs 3 [3; 4] points (р=0,02) on days 1, 2, 3 and 5 of the postoperative period, respectively. The severity of gastroenterological symptoms was higher in patients with a heterozygous CT genotype for the allelic variant CYP2C9*2 than in patients with a wild CС genotype and amounted to 19 [19; 22] vs 18 [16; 20] points, respectively, (p=0,04). The distribution of genotypes for CYP2C9*2 polymorphisms and CYP2C9*3 polymorphisms between the groups of acute renal injury did not differ significantly.Conclusion. Associations of polymorphisms CYP2C9*3 with a lower intensity of pain syndrome and CYP2C9*2 with a greater severity of gastroenterological symptoms were revealed.https://www.rpcardio.online/jour/article/view/2539postoperative analgesiacardiac surgerypharmacogeneticsacute kidney injuryketoprofen |
| spellingShingle | T. E. Morozova D. A. Shatsky N. V. Shikh E. V. Shikh T. B. Andrushchyshina M. V. Lukina A. A. Kachanova Zh. A. Sozaeva G. N. Shuev N. P. Denisenko E. A. Grishina D. A. Sychev Evaluation of the Influence of <i>CYP2C9* 2, CYP2C9*3</i> Gene Polymorphisms on the Efficacy and Safety of Postoperative Analgesia with Ketoprofen in Patients after Cardiac Surgery Рациональная фармакотерапия в кардиологии postoperative analgesia cardiac surgery pharmacogenetics acute kidney injury ketoprofen |
| title | Evaluation of the Influence of <i>CYP2C9* 2, CYP2C9*3</i> Gene Polymorphisms on the Efficacy and Safety of Postoperative Analgesia with Ketoprofen in Patients after Cardiac Surgery |
| title_full | Evaluation of the Influence of <i>CYP2C9* 2, CYP2C9*3</i> Gene Polymorphisms on the Efficacy and Safety of Postoperative Analgesia with Ketoprofen in Patients after Cardiac Surgery |
| title_fullStr | Evaluation of the Influence of <i>CYP2C9* 2, CYP2C9*3</i> Gene Polymorphisms on the Efficacy and Safety of Postoperative Analgesia with Ketoprofen in Patients after Cardiac Surgery |
| title_full_unstemmed | Evaluation of the Influence of <i>CYP2C9* 2, CYP2C9*3</i> Gene Polymorphisms on the Efficacy and Safety of Postoperative Analgesia with Ketoprofen in Patients after Cardiac Surgery |
| title_short | Evaluation of the Influence of <i>CYP2C9* 2, CYP2C9*3</i> Gene Polymorphisms on the Efficacy and Safety of Postoperative Analgesia with Ketoprofen in Patients after Cardiac Surgery |
| title_sort | evaluation of the influence of i cyp2c9 2 cyp2c9 3 i gene polymorphisms on the efficacy and safety of postoperative analgesia with ketoprofen in patients after cardiac surgery |
| topic | postoperative analgesia cardiac surgery pharmacogenetics acute kidney injury ketoprofen |
| url | https://www.rpcardio.online/jour/article/view/2539 |
| work_keys_str_mv | AT temorozova evaluationoftheinfluenceoficyp2c92cyp2c93igenepolymorphismsontheefficacyandsafetyofpostoperativeanalgesiawithketoprofeninpatientsaftercardiacsurgery AT dashatsky evaluationoftheinfluenceoficyp2c92cyp2c93igenepolymorphismsontheefficacyandsafetyofpostoperativeanalgesiawithketoprofeninpatientsaftercardiacsurgery AT nvshikh evaluationoftheinfluenceoficyp2c92cyp2c93igenepolymorphismsontheefficacyandsafetyofpostoperativeanalgesiawithketoprofeninpatientsaftercardiacsurgery AT evshikh evaluationoftheinfluenceoficyp2c92cyp2c93igenepolymorphismsontheefficacyandsafetyofpostoperativeanalgesiawithketoprofeninpatientsaftercardiacsurgery AT tbandrushchyshina evaluationoftheinfluenceoficyp2c92cyp2c93igenepolymorphismsontheefficacyandsafetyofpostoperativeanalgesiawithketoprofeninpatientsaftercardiacsurgery AT mvlukina evaluationoftheinfluenceoficyp2c92cyp2c93igenepolymorphismsontheefficacyandsafetyofpostoperativeanalgesiawithketoprofeninpatientsaftercardiacsurgery AT aakachanova evaluationoftheinfluenceoficyp2c92cyp2c93igenepolymorphismsontheefficacyandsafetyofpostoperativeanalgesiawithketoprofeninpatientsaftercardiacsurgery AT zhasozaeva evaluationoftheinfluenceoficyp2c92cyp2c93igenepolymorphismsontheefficacyandsafetyofpostoperativeanalgesiawithketoprofeninpatientsaftercardiacsurgery AT gnshuev evaluationoftheinfluenceoficyp2c92cyp2c93igenepolymorphismsontheefficacyandsafetyofpostoperativeanalgesiawithketoprofeninpatientsaftercardiacsurgery AT npdenisenko evaluationoftheinfluenceoficyp2c92cyp2c93igenepolymorphismsontheefficacyandsafetyofpostoperativeanalgesiawithketoprofeninpatientsaftercardiacsurgery AT eagrishina evaluationoftheinfluenceoficyp2c92cyp2c93igenepolymorphismsontheefficacyandsafetyofpostoperativeanalgesiawithketoprofeninpatientsaftercardiacsurgery AT dasychev evaluationoftheinfluenceoficyp2c92cyp2c93igenepolymorphismsontheefficacyandsafetyofpostoperativeanalgesiawithketoprofeninpatientsaftercardiacsurgery |